Previously dba Paragon Intellectual Properties - an LLC with seven divisions - in October 2008 was renamed Nexeon MedSystems, a single corporate entity that would focus on cardiovascular devices. Coincident withthe retructuring the firm raised its first round of VC (Series A) to include major corporate suuport as well as private investors. In 2015, Nexeon underwent a change of control and was incorporated in the state of Nevada and has headquarters in Dallas, TX, with subsidiaries in San Juan, Puerto Rico, and Liege, Belgium. Nexeon Medsystems, Inc. is a global medical device company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological disease. Nexeon has developed and commercialized the Nexeon Neurostimulation System, an adaptive, closed-loop platform that can be utilized to treat a variety of neurological disease
